Estimands and Complex Innovative Designs-Reference-Cited by-同舟云学术

Estimands and Complex Innovative Designs

Published:2022-03-29 Issue:6 Volume:112 Page:1183-1190
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Collignon Olivier¹,Schiel Anja²,Burman Carl‐Fredrik³,Rufibach Kaspar⁴,Posch Martin⁵,Bretz Frank⁵⁶

Affiliation:

1. GlaxoSmithKline Hertfordshire UK

2. Norwegian Medicines Agency Oslo Norway

3. Statistical Innovation, Data Science & Artificial Intelligence AstraZeneca Research & Development Gothenburg Sweden

4. Methods, Collaboration, and Outreach Group, Product Development Data Sciences F.Hoffmann‐La Roche Basel Switzerland

5. Section for Medical Statistics Center for Medical Statistics Informatics, and Intelligent Systems Medical University of Vienna Vienna Austria

6. Novartis Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2575

Reference55 articles.

1. International Council For Harmonisation of Technical Requirements For Pharmaceuticals For Human Use (ICH).ICH E9(R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials (2019).

2. Estimands and Their Role in Clinical Trials

3. Estimands in clinical trials - broadening the perspective

4. Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice

5. Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper;Infection;2024-07-17

2. Current developments of the estimand concept;Pharmaceutical Statistics;2024-04-27

3. Developing generic templates to shape the future for conducting integrated research platform trials;Trials;2024-03-21

4. Considerations for master protocols using external controls;Journal of Biopharmaceutical Statistics;2024-02-16

5. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL;eClinicalMedicine;2024-01